Functional Neural Regeneration Collagen Scaffold Transplantation in Acute Spinal Cord Injury Patients

NCT02510365 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-12-23

No results posted yet for this study

Summary

The study is designed to assess the safety and efficacy of functional neural regeneration collagen scaffold transplanted into acute spinal cord injury patients.

Conditions

  • Acute Spinal Cord Injury

Interventions

BIOLOGICAL

Functional collagen scaffold

Patients will receive functional neural regeneration collagen scaffold and patients will undergo a comprehensive rehabilitation and psychological measures after surgery.

Sponsors & Collaborators

  • Affiliated Hospital of Logistics University of CAPF

    collaborator OTHER
  • The First Affiliated Hospital of Soochow University

    collaborator OTHER
  • First Hospitals affiliated to the China PLA General Hospital

    collaborator OTHER_GOV
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • Army Medical University, China

    collaborator OTHER
  • Chinese Academy of Sciences

    lead OTHER_GOV

Principal Investigators

  • Jianwu Dai, Ph.D · Chinese Academy of Sciences

  • Sai Zhang, M.D · Affiliated Hospital of Logistics Universtiy of CAPF

  • Huilin Yang, Ph.D · The First Affiliated Hospital of Soochow University

  • Shuxun Hou · First Hospitals affiliated to the China PLA General Hospital

  • Hechun Xia · General Hospital of Ningxia Medical University

  • Tongwei Chu · Army Medical University, China

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02510365 on ClinicalTrials.gov